TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors.

A J Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.